Application Nr Approved Date Route Status External Links
NDA208073 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Xiidra ® (Lifitegrast Ophthalmic Solution) 5% Is Indicated For The Treatment Of The Signs And Symptoms Of Dry Eye Disease (Ded). Xiidra (Lifitegrast Ophthalmic Solution) 5% Is A Lymphocyte Function-Associated Antigen-1 (Lfa-1) Antagonist Indicated For The Treatment Of The Signs And Symptoms Of Dry Eye Disease (Ded). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lifitegrast LIFITEGRAST ZINC84668739

Comments